Form 4 for APRE Aprea Therapeutics, Inc.
Accepted 2021-08-27 00:00:00 ET · period of report 2021-08-25 · accession 0001104659-21-110596 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-27 | 2021-08-25 | APRE | Coiante Scott M | SVP, CFO | F - Tax | $3.98 | -7,534 | 91.5K | -8% | -$30.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-25 | F | D | 7,534 | $3.98 | 91,466 | D | — | — | (F1) Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of 21,166 restricted stock units. |